All Pharma News
Novo Nordisk offloads preclinical cancer candidate from $1.1B Forma buyout

Novo Nordisk offloads preclinical cancer candidate from $1.1B Forma buyout
Amber Tong ENDPTS
02 Mar 2023
Share Share
Rigel wins US approval of rival drug to Servier leukemia treatment

Rigel wins US approval of rival drug to Servier leukemia treatment
Christopher Newman BIOPHARMADIVE
03 Dec 2022
Share Share
Novo Nordisk announces the completion of the Forma Therapeutics acquisition

Novo Nordisk announces the completion of the Forma Therapeutics acquisition
GLOBENEWSWIRE
14 Oct 2022
Share Share
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders
PRESS RELEASE
01 Sep 2022
Share Share
Forma Therapeutics Reports Second Quarter 2022 Financial Results

Forma Therapeutics Reports Second Quarter 2022 Financial Results
BUSINESSWIRE
05 Aug 2022
Share Share
Rigel bets $230M on Forma`s leukemia drug

Rigel bets $230M on Forma`s leukemia drug
Gabrielle Masson FIERCEBIOTECH
02 Aug 2022
Share Share
Rigel and Forma Announce Licensing Agreement for Olutasidenib in r/r AML

Rigel and Forma Announce Licensing Agreement for Olutasidenib in r/r AML
PRNEWSWIRE
02 Aug 2022
Share Share
Forma Therapeutics to Report Second Quarter 2022 Financial Results

Forma Therapeutics to Report Second Quarter 2022 Financial Results
BUSINESSWIRE
29 Jul 2022
Share Share
Forma Therapeutics Announces Appointment of New Executive Team Members

Forma Therapeutics Announces Appointment of New Executive Team Members
BUSINESSWIRE
30 Jun 2022
Share Share
Forma Therapeutics Announces Presentations at Upcoming Hematology Conference

Forma Therapeutics Announces Presentations at Upcoming Hematology Conference
BUSINESSWIRE
10 Jun 2022
Share Share